| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 3.14%321.19 | 311.42 | 295.88 | 286.56 | 316.96 |
| Cost Of Revenue | 6.47%109.80 | 103.13 | 104.60 | 98.44 | 118.15 |
| Gross Profit | 1.49%211.39 | 208.29 | 191.28 | 188.11 | 198.81 |
3.26%137.12 | 132.79 | 136.82 | 140.45 | 222.67 | |
| Selling, General, and Administrative | 3.51%113.17 | 109.34 | 113.69 | 116.21 | 196.64 |
| Operating Income/Loss | 1.61%74.28 | 75.50 | 54.46 | 47.66 | -23.86 |
| Nonoperating Income/Loss | 15.78%-3.60 | -4.27 | -3.68 | 0.33 | 1.00 |
| Income/Loss From Equity Method Investments | 265.36%1.22 | -0.74 | 0.11 | 0.29 | 1.11 |
| Income/Loss From Continuing Operations Before Tax | 0.77%70.68 | 71.23 | 50.78 | 47.99 | -22.86 |
| Income Tax Expense/Benefit | 20.41%16.06 | 20.18 | 12.78 | 9.81 | -5.18 |
7.00%54.62 | 51.05 | 38.01 | 38.19 | -17.68 | |
| Available To Common Stockholders, Basic | 7.06%54.64 | 51.04 | 38.00 | 38.18 | -17.70 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic | 290.00%-0.02 | 0.01 | 0.01 | 0.01 | 0.02 |